CONMED Corporation CNMD
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 592.41% | 7.70% | 129.09% | -50.41% | -94.16% |
| Total Depreciation and Amortization | 3.10% | 2.56% | 3.20% | 6.29% | 3.52% |
| Total Amortization of Deferred Charges | -52.19% | -24.06% | -11.57% | -3.69% | -11.57% |
| Total Other Non-Cash Items | 12.37% | -1.51% | -74.66% | 80.00% | 152.23% |
| Change in Net Operating Assets | -104.59% | 35.91% | -3,922.64% | 32.91% | 1,664.35% |
| Cash from Operations | -7.96% | 27.33% | -67.56% | 6.92% | 4.85% |
| Capital Expenditure | 48.26% | 48.79% | 23.47% | -26.51% | -51.71% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 63.93% | 301.89% | 240.25% | -76.01% | -51.71% |
| Total Debt Issued | 0.60% | 331.06% | 8.43% | 24.67% | 16.78% |
| Total Debt Repaid | 4.78% | -317.72% | 14.17% | -11.29% | -15.98% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -0.23% | -0.42% |
| Other Financing Activities | -45.51% | -123.23% | -38.09% | -25.71% | -25.01% |
| Cash from Financing | 15.09% | -74.29% | 20.58% | 26.83% | -12.09% |
| Foreign Exchange rate Adjustments | 205.00% | -108.21% | -199.39% | 101.52% | -96.90% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 113.14% | 248.26% | -152.49% | 113.48% | -47.97% |